ACRES Commercial Realty (ACR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
11 May, 2026Executive summary
Annual meeting scheduled for June 22, 2026, with virtual participation and voting options for shareholders.
Key proposals include director elections, say-on-pay, auditor ratification, stock issuance for a merger, adoption of a new equity incentive plan, and potential adjournment.
The main strategic action is the Internalization Merger, transitioning from external to internal management by acquiring ACC and its manager.
The merger aims to enhance governance, reduce costs, align management and shareholder interests, and increase transparency.
Voting matters and shareholder proposals
Election of nine directors to serve until the 2027 annual meeting.
Advisory vote on executive compensation (say-on-pay).
Ratification of PricewaterhouseCoopers LLP as independent auditor for 2026.
Approval of issuance of approximately 7.5 million shares for the Internalization Merger.
Approval of the 2026 Omnibus Equity Incentive Plan, reserving 1,432,172 shares for awards.
Proposal to adjourn the meeting if more time is needed to solicit votes.
Board of directors and corporate governance
Board consists of nine nominees, with a majority classified as independent under NYSE rules.
Four standing committees: Audit, Compensation, Nominating/ESG, and Investment.
Annual board and committee self-assessment and director re-nomination process.
Stockholders have the right to amend bylaws and submit director nominations.
Board leadership is separated between Chairman and CEO roles.
Latest events from ACRES Commercial Realty
- Key votes include director elections, merger internalization, and new equity incentives.ACR
Proxy filing11 May 2026 - Q1 2026 featured a $3.3M real estate gain, $1B securitization, and a merger/internalization.ACR
Q1 20267 May 2026 - Stockholders to vote on internalization merger, new equity plan, and key governance proposals.ACR
Proxy filing1 May 2026 - $571M in new loans, $3M net loss, book value up to $30.01, and $1B CRE CLO closed.ACR
Q4 20255 Mar 2026 - Net income and book value rose, with 79% of loans in multifamily and strong liquidity.ACR
Q2 20242 Feb 2026 - Q3 2024 net income rose to $2.8M, book value per share hit $27.92, and liquidity stayed strong.ACR
Q3 202417 Jan 2026 - Q1 net loss, portfolio contraction, and new $939.9M facility amid elevated credit risk.ACR
Q1 202524 Dec 2025 - Book value and EAD rose on asset sales; strong multifamily loans and portfolio growth expected.ACR
Q4 202424 Dec 2025 - Annual meeting to vote on directors, Say on Pay, auditor, and highlight ESG and governance.ACR
Proxy Filing1 Dec 2025